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ABSTRACT Two-dimensional polyacrylamide gel electro-
phoresis and the radioligand (-)-[25I]iodopindolol ('25I-Pin)
have been used to study isoproterenol-dependent protein phos-
phorylation and /3-adrenergic receptor availability, respective-
ly, in cultured Sertoli cells and freshly isolated seminiferous
tubular segments of sexually immature and mature rats. Ser-
toli cells prepared from sexually immature rats show progres-
sive 12'I-Pin binding in primary cultures that correlates with
isoproterenol-induced cell shape changes, redistribution of im-
munoreactive vimentin, and phosphorylation of this interme-
diate filament protein. The development of 125I-Pin binding to
Sertoli cell lysates is blocked by cycloheximide. Seminiferous
tubules do not show significant isoproterenol-dependent vi-
mentin phosphorylation nor '2I-Pin binding. However, vi-
mentin phosphorylation can be induced by follicle-stimulating
hormone or a cyclic nucleotide analog. This study stresses the
need for correlating pharmacological-induced responses ob-
served in Sertoli cell primary cultures with those in the intact
seminiferous tubule.
adrenergic response is acquired by these cells during pri-
mary culture as the result of newly synthesized f3-adrenergic
receptors (14, 15). This possibility was examined in both pri-
mary cultures of Sertoli cells and freshly isolated seminifer-
ous tubules by comparing FSH and isoproterenol-induced
protein phosphorylation. These findings were correlated
with the binding of the radioligand (-)-[125I]iodopindolol
(125I-Pin) to fB-adrenergic receptors. It was found that, al-
though in cultured Sertoli cells both FSH and isoproterenol
induced the phosphorylation of vimentin and other intracel-
lular proteins, only FSH, not isoproterenol, stimulated pro-
tein phosphorylation in isolated seminiferous tubules. These
findings correlated with the time-dependent acquisition of
125I-Pin binding to p-adrenergic receptors by cultured Sertoli
cells. Sertoli cells or any other cell of the intact seminiferous
tubule could be shown to contain f-adrenergic receptors.
MATERIALS AND METHODS
The Sertoli cell, a somatic cell component of the seminifer-
ous tubule, is the primary target for follicle-stimulating hor-
mone (FSH). FSH action on rat Sertoli cells in primary cul-
ture is mediated in part by the activation of cAMP-depen-
dent protein kinases (1, 2). Activation of cAMP-dependent
protein kinases results in the phosphorylation of specific
protein substrates (3), which in turn modulate many of the
subsequent physiological cell responses (4). We reported
that FSH stimulates the phosphorylation of various Sertoli
cell intracellular proteins, including the intermediate fila-
ment protein vimentin (5, 6). FSH-dependent phosphoryl-
ation of vimentin is preceded by a surge of both intracellular
cAMP and protein-bound cAMP levels (6-8), which are
maximized by using a phosphodiesterase inhibitor. Protein-
bound cAMP levels reflect the binding of cAMP to regula-
tory subunits of cAMP-dependent protein kinases as deter-
mined by using a photoaffinity analog (8). Stimulation of cul-
tured Sertoli cells with isoproterenol results in an increase of
intracellular cAMP levels that also is enhanced by the pres-
ence of a phosphodiesterase inhibitor (9-12). Isoproterenol
mimics several effects induced on cultured Sertoli cells by
FSH and/or cyclic nucleotide analogs (12). Although the
presence of /3-adrenergic receptors in cultured Sertoli cells
has been reported (13), the physiological significance of j-
adrenergic agonist action on components of the seminiferous
tubule is not known. The question then arises: to what extent
are isoproterenol responses induced in cultured Sertoli cells
reproduced by this cell within the intact seminiferous tu-
bule? This is a relevant question in light of recent evidence
obtained from the study of rat hepatocytes showing that a ,B
Materials. Ovine FSH (NIH-oFSH-S15) was from Nation-
al Hormone and Pituitary Program of National Institute of
Arthritis, Metabolism, and Digestive Diseases. N'6,o2-Dibu-
tyryladenosine 3',5'-phosphate (Bt2cAMP), L-isoproterenol,
(-)-isoproterenol bitartrate, and cycloheximide were from
Sigma. 3-Isobutyl-1-methylxanthine (iBuMeXan) was from
Aldrich. Carrier-free [32P]orthophosphate was from New
England Nuclear. Gel electrophoresis reagents were from
Bio-Rad and Pharmacia. Vimentin rabbit antiserum was pro-
vided by K. Burridge. Fluorescein isothiocyanate-conjugat-
ed goat anti-rabbit IgG was from Cappel Laboratories (Coch-
ranville, PA). (-)-Pindolol was a generous gift from Sandoz
Pharmaceutical. 125I-Pin was prepared by the method of Bar-
ovsky and Brooker (16).
Sertoli Cell Culture. Sertoli cell cultures were prepared as
described (17) from sexually immature rats (20-22 days old).
Contamination with peritubular cells was less than 5%. Con-
tamination with spermatogenic cells (125I-Pin binding stud-
ies) was about 25%. Sertoli cell plating concentration was 1
x 106 cells/ml.
Seminiferous Tubules. Seminiferous tubules from sexually
mature rats (75-80 days old) were gently teased apart in
Hanks' balanced salt solution under sterile conditions and
examined immediately by transillumination (18) with a ster-
eomicroscope. Pools of interstitial tissue-free seminiferous
tubular segments (6-8 segments, 2-3 mm in length) corre-
sponding to specific spermatogenic stages or to a mixture of
several spermatogenic stages were collected in HBSS and
Abbreviations: 125I-Pin, (-)-['25j]iodopindolol; FSH, follicle-stimu-
lating hormone; Bt2cAMP, N6,02'-dibutyryladenosine 3',5'-phos-
phate; iBuMeXan, 3-isobutyl-1-methylxanthine.
*Part of this work was presented as a poster at the 23rd American
Society for Cell Biology Annual Meeting, Nov. 29-Dec. 3, 1983,
San Antonio, TX (27).
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then transferred to wells of a multiple-well plate containing
free Eagle's minimum essential medium (EME medium) (for
[32P]orthophosphate-labeling) or to culture tubes (for 8-ad-
renergic receptor determination). Pools of seminiferous tu-
bules of sexually immature rats also were examined. Specific
spermatogenic stages were verified by light microscopic ex-
amination of sections (18, 19) or "squash" preparations
stained with aceto-orcein.
Time-Lapse Cinematography. Sertoli cells were grown on
round coverslips for 4 days and placed in a Dvorak-Stotler
controlled-environment culture chamber (Zeiss). Cells were
examined with a Wild M40A inverted phase-contrast micro-
scope, and cell-shape changes were recorded on Kodak SO-
115 negative black-and-white film by using an Opti-Quip 16-
mm system as described (7). Film was exposed at a framing
rate of two frames per min.
Indirect Immunofluorescence. Immunocytochemical ex-
periments were carried out as described (6, 7). Controls for
specificity included (i) omission of primary antiserum, (ii)
absorption of antiserum with an extract of intermediate fila-
ment proteins (6), and (iii) immunoprecipitation of [35S]_
methionine-labeled vimentin (6).
[32P]Orthophosphate Labeling. Sertoli cells plated in cul-
ture dishes for 6-7 days were maintained in serum-free EME
medium for 18-24 hr prior to incubation with the chemical
agents FSH, isoproterenol, and/or cyclic nucleotide ana-
logs. Cells were preincubated for 30 min with serum-free,
phosphate-free EME medium before labeling to deplete the
endogenous ATP pool. [32P]Orthophosphate (250 ACi/ml; 1
Ci = 37 GBq) was added to fresh serum-free, phosphate-free
EME medium prior to or with chemical agents. The endoge-
nous ATP pool was equilibrated within 90 min after exposure
to [32P]orthophosphate (not shown). Cells were incubated at
320C for 4 hr in a humidified atmosphere. Dishes were rinsed
with cold phosphate-buffered saline (pH 7.2), and then 200
A1l of lysis buffer (20) was added. Cells were scraped from
the dishes and dispersed by sonication. Seminiferous tubular
segments were incubated in serum-free EME medium for 1
hr at 320C. The medium was replaced with serum-free, phos-
phate-free EME medium, and the segments were incubated
at 32°C for an additional hour. The medium was aspirated,
and seminiferous tubular segments were labeled with
[32P]orthophosphate by addition prior to or with chemical
agents as described above for Sertoli cells. Segments were
incubated for 4 hr at 32°C. Incubation was terminated by
rinsing the wells with ice-cold phosphate-buffered saline and
then adding 150 t.d of lysis buffer to each well. The segments
were collected on ice and dispersed by sonication.
Two-Dimensional Polyacrylamide Gel Electrophoresis and
Autoradiography. Aliquots of the sonicated cell and tissue
samples were counted by spotting on filter paper squares as
described (6, 21). Samples containing the same number of
counts were then analyzed by two-dimensional polyacrylam-
ide gel electrophoresis and autoradiography as described (5,
6, 21).
Binding of 125I-Pin. Sertoli cells were washed with EME
medium and incubated for 20 min with an ice-cold hypotonic
buffer containing 1 mM Tris (pH 7.8) and 0.5 mM MgCl2,
after which cells were visibly swollen. The buffer was re-
moved, and cells were scraped with a rubber policeman.
Seminiferous tubules were homogenized in 1.5 ml of hypo-
tonic buffer with 15 strokes of a teflon/glass homogenizer.
Lysates were collected and diluted to 3 ml with 20 mM Tris,
pH 7.4/140 mM NaCl/2 mM MgCl2. Dilutions of 1:3, 1:9,
1:27, and 1:54 were made from this concentrated solution.
All dilutions were assayed by incubation for 60 min at 25°C
with 130 pM 125I-Pin in either 100 ,uM HCl (to determine
total binding) or 100 ,uM (-)-isoproterenol bitartrate in 100
AM HCO (to determine nonspecific binding). Cell membranes
were collected onto glass fiber filters, washed to lower non-
specific binding, and assayed for radioactivity at about 82%
efficiency. Proteins were determined by the method of Low-
ry. Dilution curves (not shown) demonstrate a linear rela-
tionship between the amount of 125I-Pin bound versus pro-
tein concentration.
RESULTS
Sertoli Cell-Shape Changes Induced by Isoproterenol. We
have reported that FSH and cyclic nucleotide analogs induce
morphologically flat Sertoli cells in culture to adopt a stellate
morphology (7). Whereas cyclic nucleotide analogs induced
a persistent morphological transition, FSH-triggered cell-
shape changes were transient, as they reversed progressive-
ly to control conditions within 24 hr (7). Therefore, it was of
interest to document the effect of isoproterenol (10 uM) on
Sertoli cell morphological response. Fig. LA illustrates a
time-lapse sequence showing that after 15 min of exposure to
this chemical agent (iBuMeXan not present), most Sertoli
cells adopted a stellate morphology. This morphological re-
sponse was transient because 150 min later the same Sertoli
cells regressed to a flattened state while isoproterenol was
present in the culture medium. Other Sertoli cells present in
the same preparation remained contracted and initiated re-
covery 4 hr after exposure to isoproterenol. Fig. 1 B and C
show the immunofluorescent distribution of vimentin in con-
trol cells and isoproterenol-treated Sertoli cells after 60 min.
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FIG. 1. Time-lapse cinematographic sequence of cultured Senoli
cells prepared from a 22-day-old rat and exposed to isoproterenol
(10 jM) 4 days after plating. Cells were placed in serum-free EME
medium for 12 hr and then were exposed continuously to isoprotere-
nol. Numbers show time in min after initial exposure to the agent.
(x 150.) (B and C) Immunocytochemical localization of vimentin in
control Sertoli cells (B) and after 60 min of treatment with 10 ,uM
isoproterenol (C) (x240.) The working dilution of primary antibody
was 1:50.
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Bt2cAMP (6), the diffuse and perinuclear filamentous net-
work of immunoreactive vimentin observed in control Ser-
toli cells (Fig. 1B) appeared to be restricted to the long cyto-
plasmic processes and the perinuclear region of morphologi-
cally responsive Sertoli cells (Fig. 1C). Although treatment
with FSH and isoproterenol resulted in similar vimentin im-
munofluorescent patterns, the morphological response of
Sertoli cells to isoproterenol was more rapid and extensive.
FSH- and Isoproterenol-Dependent Phosphorylation in Cul-
tured Sertoli Cells. Because time-lapse cinematographic and
immunocytochemical results indicated that both FSH and
isoproterenol induced comparable responses, we examined
the effect of these two agents on protein phosphorylation in
cultured Sertoli cells in the presence or absence of the phos-
phodiesterase inhibitor iBuMeXan (0.2 mM). Treatment of
Sertoli cells with FSH (10 pkg/ml) in the presence of iBu-
MeXan resulted in marked [32P]orthophosphate uptake by
four polypeptides of Mr/PI 58,000/5.1, 46,000/4.95,
48,000/5.0, and 26,000/5.6 (Fig. 2). Phosphoprotein of
Mr/pI 58,000/5.1 has been identified as vimentin (6, 21), and
two of the additional phosphoproteins (Mr/pT 46,000/4.95
and 48,000/5.0) probably represent degradation products of
vimentin (5, 6, 22). The observed changes were consistent
with an earlier study showing potentiation ofcAMP action in
the presence of iBuMeXan (6) and correlated with the obser-
vation that only a slight increase in the phosphorylation of
these four polypeptides was induced by FSH in the absence
of iBuMeXan (not shown). Treatment of Sertoli cells with
isoproterenol (20 ,uM) in the presence of iBuMeXan induced
phosphorylation of the same four polypeptides comparable
to that observed with FSH and iBuMeXan (Fig. 2). Although
treatment with isoproterenol or iBuMeXan alone caused no
change in the protein phosphorylation patterns (not shown),
the cAMP analog Bt2cAMP (0.5 mM) mimicked the phos-
phorylation changes induced by FSH/iBuMeXan and iso-





















that the effects of FSH and isoproterenol on protein phos-
phorylation were mediated by a cAMP-dependent mecha-
nism after binding of these chemical agents to specific cell-
surface receptors.
FSH- and Isoproterenol-Dependent Protein Phosphoryl-
ation in Isolated Seminiferous Tubular Segments. Our next
approach was to correlate the protein phosphorylation pat-
terns induced by FSH and isoproterenol in cultured Sertoli
cells with those observed in intact seminiferous tubular seg-
ments, free of interstitial tissue, isolated by mechanical
means from sexually immature and mature rats. Fig. 3 illus-
trates protein phosphorylation patterns of seminiferous tu-
bular segments of spermatogenic stages VIII-IX identified
by transillumination and verified by histological methods
(not shown). FSH (10 ,ug/ml) treatment resulted in only
slight changes in the phosphorylation pattern of the indicated
proteins when compared with the control (Fig. 3). However,
incubation of seminiferous tubular segments with FSH in the
presence of iBuMeXan (0.2 mM) caused a significant in-
crease in the phosphorylation of five polypeptides of Mr/pI
58,000/5.1, 46,000/4.95, 48,000/5.0, 31,000/6.25, and
26,000/5.6 (Fig. 3). Four of these phosphoproteins appear to
be the same FSH-dependent phosphoproteins as those ob-
served in cultured Sertoli cells (compare with Fig. 2). The
Mr/pI 31,000/6.25 polypeptide seemed to be unique to the
seminiferous tubular segments. Interestingly, isoproterenol
(20 AM) in the presence (Fig. 3) or absence (not shown) of
iBuMeXan had only a slight effect on the phosphorylation of
these five polypeptides. Whereas iBuMeXan alone had no
effect on the protein phosphorylation pattern (not shown),
Bt2cAMP (0.5 mM) effects were comparable to these ob-
served after FSH and iBuMeXan treatment (Fig. 3). These
results suggested a discrepancy in isoproterenol effect on
protein phosphorylation in cultured Sertoli cells and incubat-
ed seminiferous tubular segments. Seminiferous tubular seg-




FIG. 2. Two-dimensional polyacryl-
amide gel electrophoretic analysis of
protein phosphorylation patterns of cul-
tured Sertoli cells prepared from sexual-
ly immature rats. Cells were incubated
for 4 hr in the presence of [32P]ortho-
phosphate (250 ;kCi/ml) in phosphate-
free, serum-free EME medium with (i)
FSH (10 Ag/ml) and 0.2 mM iBuMeXan
(MIX), (it) isoproterenol (ISO, 20 IM)
and 0.2 mM iBuMeXan, or (iii) Bt2cAMP
(0.5 mM). The rectangle and square indi-
cate relevant protein phosphorylation
changes. Vimentin and its degradation
products are indicated by the rectangle.
Numbers indicate Mr x i0-0 markers.
The pH range of the gel was 4.5-6.8 as
_ | determined by pH measurement of gel
slices. Autoradiographs were obtained
basic after exposure of the gels for 3 days.
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FIG. 3. Two-dimensional polyacrylamide gel electrophoretic
analysis of protein phosphorylation patterns of freshly isolated sem-
iniferous tubular segments corresponding to the transition between
spermatogenic stages VIII and IX. Segments were incubated in the
presence of [32P]orthophosphate (250 ,Ci/ml) for 4 hr with (i) FSH
(10 Ag/ml) with or without iBuMeXan (MIX) (0.2 mM), ih) isoproter-
enol (ISO, 20 AM) with iBuMeXan (0.2 mM) and (iii) Bt2cAMP (0.5
mM). The rectangle and squares indicate relevant protein phospho-
rylation changes. Vimentin and its degradation products are indicat-
ed by the rectangle. Numbers indicate Mr x 10-3 markers. The pH
range of the gel was 4.5-6.8. Autoradiographs were obtained after
exposing the gels for 12-15 days.
spermatogenic stages of sexually mature rats were examined
with similar results.
'2I-Pin Binding to ,B-Adrenergic Receptors. A radioligand
with high-affinity binding to P-adrenergic receptors (23, 24)
was used to determine whether the differential isoprotere-
nol-induced protein phosphorylation in cultured Sertoli cells
and incubated seminiferous tubular segments was due to the
availability of receptor sites. A time-course study was car-
ried out to determine the temporal appearance of 83-adrener-
gic receptors in cultured Sertoli cells prepared from sexually
0 4 12 48
Time, hr
FIG. 4. 3-Adrenergic receptor content determined by 125IPin
binding to lysates of cultured Sertoli cells prepared from sexually
immature rats. The abscissa is culture time in hours after plating at
time 0. The points are averages of different experiments (indicated
by numbers on the left of the points), each using triplicate samples.
Bars represent SEMs.
immature rats. Fig. 4 shows at time 0 almost undetectable
125I-Pin binding to cell membrane preparations of trypsin/
collagenase-dissociated seminiferous epithelial samples
(containing mainly Sertoli cells and premeiotic and early
meiotic prophase spermatocytes). Radioligand binding to
Sertoli cells was detected at 4 hr after plating in serum-sup-
plemented EME medium (calculated f3-adrenergic receptor
content, 4.72 ± 1.41 fmol). ,8-Adrenergic receptor content
values were 10.07 ± 0.17 and 9.73 ± 0.11 fmol at 12 and 48
hr, respectively.
We next examined the possibility that f3-adrenergic recep-
tors were synthesized de novo by Sertoli cells when cultured
as monolayers for 24 hr. Table 1 shows 1251-Pin specific
binding activity to /3-adrenergic receptors (expressed as av-
erage cpm and determined fmol per assay) of cultured Sertoli
cells for 6 and 24 hr in the presence or absence of cyclohexi-
mide (10 ,uM). Results indicate that cycloheximide blocks
Table 1. Specific 125I-Pin binding activity to lysates of cultured
rat Sertoli cells and freshly-isolated and incubated seminiferous
tubules in the presence or absence of cycloheximide
Sample Time, hr n Mean cpm fmol/assay
Cultured Sertoli cells (sexually immature)
Control 0* 3 528 0.133
6 3 515 0.130
24 3 1548 0.399
Cycloheximide 0* 2 264 0.066
6 2 331 0.084
24 3 403 0.102
Seminiferous tubules (sexually immature)
Control Ot 2 72 0.018
4 2 58 0.015
Cycloheximide Ot 2 83 0.021
4 2 65 0.016
Seminiferous tubules (sexually mature)
Control 0t 1 85 0.017
Cycloheximide ND ND
Values are averages of experiments (n) done with duplicate and
triplicate samples. ND, not determined.
*Sertoli/spermatogenic cell ratio = 3.0.
tSertoli/spermatogenic cell ratio = 1.86.
tSertoli/spermatogenic cell ratio = 0.25.
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the development of 125I-Pin specific binding. The insignifi-
cant binding of 1251-Pin observed at time 0 in trypsin (0.25
mg/ml)/collagenase-treated samples was not due to trypsin
impairment of radioligand binding to specific receptor sites.
-3-Adrenergic receptors are resistant to the used concentra-
tion of trypsin (23, 25). In fact, homogenized seminiferous
tubules isolated from sexually immature and mature rats
without enzymes displayed low 125I-Pin binding when incu-
bated in serum-supplemented EME medium for 0 and 4 hr in
the presence or absence of cycloheximide (Table 1). The re-
duced 125I-Pin binding to (-adrenergic receptors in seminif-
erous tubular segments of sexually immature rats was not
age-dependent. Pools of seminiferous tubules of sexually
mature rats also showed extremely low radioligand specific
binding values (Table 1).
DISCUSSION
We have used the radioligand 125I-Pin, a potent f3-adrenergic
antagonist with high affinity for f3-adrenergic receptors and a
low level of nonspecific binding (23, 24), to provide experi-
mental evidence that rat Sertoli cells in primary culture ac-
quire f-adrenergic receptors. The ability of cultured Sertoli
cells to respond to isoproterenol in a cAMP-dependent man-
ner has been determined by protein phosphorylation studies
under conditions that enhance cAMP-dependent protein ki-
nase activity. Previous studies have shown that isoprotere-
nol first activates and then down-regulates the cAMP-gener-
ating pathway (9-12). However, a direct measurement of P-
adrenergic receptor content in cultured Sertoli cells has not
been attempted.
Sertoli cells exposed continuously to isoproterenol show a
shape change that is transient and correlates with both a re-
distribution and phosphorylation of vimentin-type intermedi-
ate filaments. Similar findings were reported for cultured
Sertoli cells stimulated with FSH (6). After isoproterenol or
FSH treatment, cultured Sertoli cells become refractory to a
subsequent stimulation with these agents, in part due to an
increase in phosphodiesterase activity that accelerates
cAMP catabolism (10, 11). It is possible that this desensitiza-
tion process accounts for the transient nature of Sertoli cell
shape changes documented by time-lapse cinematography
(7). Vimentin phosphorylation induced by FSH, isoprotere-
nol, and Bt2cAMP represents a measure of both Sertoli cell
responsiveness and cAMP-dependent protein kinase activa-
tion (6, 8). In fact, immunocytochemical studies have shown
that, in the seminiferous tubule, vimentin is mainly associat-
ed with Sertoli and peritubular cells (26). Furthermore, FSH-
dependent phosphorylation of vimentin in cultured peritubu-
lar cells was not detected (unpublished data). The functional
role of this phosphoprotein remains to be determined. How-
ever, because incubated seminiferous tubular segments
show neither vimentin phosphorylation nor "2I-Pin binding,
it is possible to conclude that isoproterenol responsiveness
of Sertoli, peritubular, and spermatogenic cells in vivo may
be reduced.
The major findings of the present study are: (i) the low
binding of 125I-Pin to homogenates of seminiferous tubules
isolated from both sexually immature and mature rats, (ii)
the time-dependent appearance of 125I-Pin binding sites in
cultured Sertoli cells, (iii) the apparent blocking effect of cy-
cloheximide on the development of 125I-Pin binding to P-ad-
renergic receptors in cultured Sertoli cells, and (iv) the ap-
parent inability of Sertoli cells within the seminiferous tubule
to exhibit 125I-Pin binding after a 4-hr incubation-a condi-
tion that favors specific binding of this radioligand to cul-
tured Sertoli cells. A possible interpretation of these findings
is that, under normal conditions, the P-adrenergic receptor is
probably not present in the cellular components of intact
seminiferous tubules. Upon being cultured, Sertoli cells ac-
quire both /3-adrenergic receptors and responsiveness to /3-
adrenergic agonists. This interpretation correlates with re-
cent observations in adult male rat hepatocytes that are nor-
mally unresponsive to (3-adrenergic receptor agonists but
acquire adrenergic responsiveness after culturing (14, 15).
Acquisition of -3-adrenergic response by cultured hepato-
cytes was abolished by cycloheximide and a-amanitin (14)
and was unaffected by factors present in serum-supplement-
ed culture media. Serum-free, hormone-supplemented cul-
ture media did not suppress the fl-adrenergic response nor
[125I]iodocyanopindolol binding affinity to receptor (15).
Findings reported in our study show the need for correlat-
ing cellular responses observed in primary culture with those
in the intact tissue. However, the possibility cannot be disre-
garded that, under pathological conditions that alter testicu-
lar functions, Sertoli cells or other testicular cell components
may display 8-adrenergic responsiveness in vivo.
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